EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers | Gut
EGFR pathway in NSCLC. Mutations, amplification or overexpression of... | Download Scientific Diagram
Common resistance mechanisms to EGFR TKIs in EGFR-mutated lung... | Download Scientific Diagram
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study | BMC Cancer | Full Text
Frontiers | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Frontiers | Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors
Distinct types of EGFR gene amplification identified in non-small cell... | Download Scientific Diagram
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks | Cancer Biology & Medicine
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis - eBioMedicine
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
EGFR | Cancer Genetics Web
Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer | British Journal of Cancer
Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options - ScienceDirect
Cancers | Free Full-Text | EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Cells | Free Full-Text | Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer
Status of EGFR mutation and gene amplification in primary Chinese lung... | Download Scientific Diagram
MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib - Nishiyama - 2020 - Cancer Science - Wiley Online Library
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
EGFR mutations and other main aberrations in lung and brain tumors.... | Download Scientific Diagram
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
XL EGFR amp - Amplification Probe | MetaSystems Probes
Targeted therapies in lung cancer and Biomarkers
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer | Biomarker Research | Full Text
